Showing results (791-800 of 824) with videos related to

Sort By:
Pageof 83
Viruses|September 28, 2021
Emergence and Spread of a B.1.1.28-Derived P.6 Lineage with Q675H and Q677H Spike Mutations in UruguayNatalia Rego, Cecilia Salazar, Mercedes Paz, et al.
Nature Immunology|October 17, 2018
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegenerationJae Kyu Ryu, Victoria A Rafalski, Anke Meyer-Franke, et al.
Critical Care Medicine|August 16, 2014
International study on microcirculatory shock occurrence in acutely ill patientsNamkje A R Vellinga, E Christiaan Boerma, Matty Koopmans, et al.
The Lancet. Infectious Diseases|November 14, 2021
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi methodPrashant Nasa, Elie Azoulay, Arunaloke Chakrabarti, et al.
Critical Care Medicine|August 4, 2025
The Association of ICU Acuity and Organizational Factors With Outcomes of Low-Risk PatientsEmmanuel S Salgueiro, Pedro Kurtz, Lunna P Borges, et al.
JAMA|September 3, 2020
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis, Jonathan A C Sterne, Srinivas Murthy, et al.
JAMA|September 21, 2021
Effect of Slower vs Faster Intravenous Fluid Bolus Rates on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical TrialFernando G Zampieri, Flávia R Machado, Rodrigo S Biondi, et al.
Lancet (London, England)|September 8, 2020
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trialRemo H M Furtado, Otavio Berwanger, Henrique A Fonseca, et al.
JAMA|August 10, 2021
Effect of Intravenous Fluid Treatment With a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical TrialFernando G Zampieri, Flávia R Machado, Rodrigo S Biondi, et al.
JAMA|September 3, 2020
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical TrialBruno M Tomazini, Israel S Maia, Alexandre B Cavalcanti, et al.
Pageof 83